Michael Kassiou

G'day mate! We cannot wait to see you in just ONE WEEK at iSRS 2025 in sunny, Gold Coast Australia! Check out the website for detailed program information, venue maps, things to do, and more! iSRS 2025 Home — srsweb.org

For more information on the pre-symposium workshop series check out: Presymposium Workshops — srsweb.org/isrs2025-works…

Join us before iSRS 2025 for a series of pre-symposium workshops on Sunday, May 11, from 9:15-16:45! The second workshop “Radiopharmaceuticals: From Bench to Bedside” will be from 11:45-13:30. Hope to see you there!

Excellent flash talk given by Andrew Montgomery today on the optimised synthesis of the radiolabeling precursor and analytical standard of [18F]-Florzolotau. #MCCB2025 #RACI

Kassiou & Danon Christmas Party 2024

The deadline for iSRS 2025 abstract submission is Monday, December 2, 2024. Don’t miss your chance to share your research in Gold Coast, Australia! Learn more: srsweb.org/isrs2025-abstr…

Huge congrats to our PhD students Chianna, Nick and Dane and our post-doc Andrew for their poster presentations at #RACIORGANIC24 last night!

✨🎓 We had an inspiring afternoon yesterday hosting Session 2 of "I have a PhD, now what?" focusing on commercialisation, investment and IP 🎓 Many thanks to our guest speakers Dr Megan O'Connor, Rachel Hooke, Dr Akshita Wason, and master of ceremonies @TitchDanon!

📸This year we received outstanding images of research in action for the DDI Research Image Contest 2024! 👏Congratulations to Winner Dr @WilliamRyder_ for his image "Actin' Crazy" (left), and Runner-up Dr Nick Shields for “The Dark Side of the (Spheroid) Moon” (right).

Thank you to presenters, panellists, and audience who brought the first-ever NSW Drug Discovery Forum to life! 👏Congratulations to Dr Philip Kwok, winner of the @AbinitioPharma ABVANCE Commercialisation Award, and Dr Ben Johnson, winner of the @AusBiotech 2025 Conference award.

Great to be at the Inaugural NSW Drug Discovery Forum. An exciting day of innovation ahead @AnneCONeill opens the proceedings @MedResearchNSW @Sydney_DDI @duncan_macinnis @MTPConnect_AUS

Exciting day coming up at the inaugural NSW Drug Discovery Forum, organised in partnership with @MTPConnect_AUS. Great to be welcomed by Duncan Macinnis, @MichaelKassiou, and hear opening remarks from @AnneCONeill. Many thanks to our sponsors @AbinitioPharma and @AusBiotech!

💡Last Friday we hosted the first workshop for the Sydney Anti-Bacterial Accelerator with @Sydney_ID! Thanks to attendees, and @DoyleMT1. Together, we revisited the history of antibiotic discovery, with an eye to meeting the challenge of antimicrobial resistance through SABA.

Congratulations to our PhD student Kris and all contributors on their new review article: "Enhancing CNS mitophagy: drug development and disease-relevant models". #Mitophagy authors.elsevier.com/a/1jxn5bg0kop1F

Thrilled to announce @Sydney_Uni ranks in the top 5 for commercialisation among Oz Universities for 🔸 Active LOAs 🔸 Active startups 🔸New startups 🔸Contract income 🔸Equity holdings. Thanks to our researchers & the Commercialisation Office! 🚀 #KCA24 bit.ly/3YqJz4n

📸 The DDI Research Image Contest 2024 is on! Submit an image you have captured in the course of your research and/or in the lab for a chance to win: 🏆 First prize: $500 🥈 Runner Up: $150 👥 People's Choice: $150 bit.ly/4eJJgXR

Wonderful to see @AbinitioPharma, a @Sydney_Uni spin-off, nurturing new talent via the ABVANCE Award! 🌟 Winning research team gets $20K in services announced at the 2024 NSW Drug Discovery Forum. #Innovation #Pharma 1/2

The 2024 Drug Discovery Forum is a state-wide event & will be held on the 28-29th October. It has been made possible by @MTPConnect_AUS and @Sydney_DDI. If you don't want to miss it then register now: bit.ly/3ZZnmeK #DrugDiscovery #ResearchExcellence #researchtranslation

iSRS 2025 Abstract Submission is open! In keeping with tradition, nearly the entire program will be built on the strength of colleagues’ submission of their research. The abstract submission deadline is December 2, 2024. Learn more: srsweb.org/isrs2025-abstr…

Yesterday, the FDA approved the first drug for schizophrenia with a new mechanism of action for more than half a century. For more on this mechanism - targeting muscarinic acetylcholine receptors - here's a recent review tinyurl.com/mwpahd99 rdcu.be/dVhpp